Search

Your search keyword '"Saumya Jayakumar"' showing total 28 results

Search Constraints

Start Over You searched for: Author "Saumya Jayakumar" Remove constraint Author: "Saumya Jayakumar" Topic medicine.disease Remove constraint Topic: medicine.disease
28 results on '"Saumya Jayakumar"'

Search Results

1. Cilofexor, a Nonsteroidal FXR Agonist, in Patients With Noncirrhotic NASH: A Phase 2 Randomized Controlled Trial

2. Acoustic Radiation Force Impulse and Conventional Ultrasound in the Prediction of Cirrhosis Complicating Fatty Liver: Does Body Mass Index Independently Alter the Results?

3. Reduced immune responses to hepatitis B primary vaccination in obese individuals with nonalcoholic fatty liver disease (NAFLD)

4. An update from the Canadian Association for the Study of the Liver on the management of liver disease during the COVID-19 pandemic

5. The ASK1 inhibitor selonsertib in patients with nonalcoholic steatohepatitis: A randomized, phase 2 trial

6. Cirrhotic cardiomyopathy: Implications for liver transplantation

7. Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications

8. Longitudinal correlations between MRE, MRI-PDFF, and liver histology in patients with non-alcoholic steatohepatitis: Analysis of data from a phase II trial of selonsertib

9. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients With Cirrhosis: A Prospective Evaluation of the Clinical Frailty Scale

10. Histological improvement of non-alcoholic steatohepatitis with a prebiotic: a pilot clinical trial

11. Effects of n-3 fish oil on metabolic and histological parameters in NASH: A double-blind, randomized, placebo-controlled trial

12. Association Between Obesity and Discordance in Fibrosis Stage Determination by Magnetic Resonance vs Transient Elastography in Patients With Nonalcoholic Liver Disease

13. Hepatitis B virus testing and linkage to care in a Canadian urban tertiary referral centre: a retrospective cohort study

14. FRI-309-Hepatitis B virus B and T cell specific responses are reduced in adults with a body mass index > 35 and non-alcoholic fatty liver disease and in a mice model of NAFLD compared to adults with a BMI of > 35 patients and normal animals

15. Fulminant Viral Hepatitis

16. Noninvasive Markers of Fibrosis and Inflammation in Nonalcoholic Fatty Liver Disease

17. Impact of weight reduction on serum markers and liver histology including progression to cirrhosis in patients with nonalcoholic steatohepatitis (NASH) and bridging fibrosis

18. Rational Guide to the Use of Erythropoietin in the Treatment of HCV Infection

19. Assessment of baseline Hepatitis B Virus (HBV) immunity and HBV vaccine responses in prospectively vaccinated adults with Non Alcoholic Fatty Liver Disease (NAFLD)

20. Liver transplantation for non-alcoholic fatty liver disease—a review

21. Mycophenolate Mofetil-related Gastrointestinal Mucosal Injury: Variable Injury Patterns, Including Graft-versus-Host Disease-like Changes

22. Minimal Hepatic Encephalopathy

23. A Rapid Bedside Screen to Predict Unplanned Hospitalization and Death in Outpatients with Cirrhosis: A Prospective Study of the Clinical Frailty Scale

24. Hepatic proton density fat fraction correlates with histologic measures of steatosis and is responsive to change in those measures in a multi-center nonalcoholic steatohepatitis clinical trial

25. Risk of Bacterial Infection in Patients With Cirrhosis and Acute Variceal Hemorrhage, Based on Child-Pugh Class, and Effects of Antibiotics

26. VSL#3 ® probiotic therapy does not reduce portal pressures in patients with decompensated cirrhosis

27. Ultrastructural findings in human nonalcoholic steatohepatitis

28. The diagnostic performance of a simplified blood test (SteatoTest-2) for the prediction of liver steatosis

Catalog

Books, media, physical & digital resources